In this study, we show that patients with T1D on multiple daily insulin injections and suboptimal glycemic control who switched from other bolus insulins to FIA experienced a significant improvement in TIR due to a reduction in time spent in hyperglycemia > 250 mg/dl during daytime, as evidenced from FGM data. The gene discussed is INS; the disease is type 1 diabetes mellitus.